Skip to Main Content

Paper Details

Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy.
Expert Rev Respir Med
9
2023
COVID-19, SARS-CoV, SARS-CoV-2, SARS-CoV-2-, convalescent plasma, humanity, immunocompromised, patients, spike protein
Author NameAffiliation
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
Michael J JoynerMayo Clinic
Liise-Anne PirofskiAlbert Einstein College of Medicine and Montefiore Medical Center
Jonathon W SenefeldMayo Clinic
Shmuel ShohamJohns Hopkins University School of Medicine
Nigel PanethMichigan State University
Nigel PanethMichigan State University
  • 1 - 8

Datasets

PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink